Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial (vol 58, pg 729, 2011)

被引：0
|
作者：
Lewis, Edmund J.
机构：
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2012年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [31] Two Days of Dexamethasone Versus 5 Days of Prednisone in the Treatment of Acute Asthma: A Randomized Controlled Trial (vol 58, pg 200, 2011)
    Kravitz, Joel
    Dominici, Paul
    Ufberg, Jacob
    Fisher, Jonathan
    Giraldo, Patricia
    ANNALS OF EMERGENCY MEDICINE, 2018, 71 (01) : 9 - 9
  • [32] Medication reviews in the community: results of a randomized, controlled effectiveness trial (vol 58, pg 648, 2004)
    Sorensen, L
    Stokes, JA
    Purdie, DM
    Woodward, M
    Elliot, R
    Roberts, MS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) : 376 - 376
  • [33] Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial (vol 7, pg 606, 2019)
    Mosenzon, O.
    Wiviott, S. D.
    Cahn, A.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (08): : E20 - E20
  • [34] RETRACTED: Reduction of microalbuminuria in patients with type 2 diabetes - The Shiga Microalbuminuria Reduction Trial (SMART) (Retracted Article)
    Tomita, Koubin
    Horide, Naoki
    Kawabata, Toshihiro
    Koya, Daisuke
    Uzu, Takashi
    Maegawa, Hiroshi
    Nishimura, Masataka
    Yamada, Shyu
    Kida, Yasuo
    Hashimoto, Tetsuya
    Takahara, Noriko
    Egawa, Katuya
    Iwanishi, Masanon
    Harada, Ntsuki
    Arimura, Tetsuro
    Kadota, Aya
    Fujita, Toshiki
    Ikebuchi, Motoyoshi
    Sakamoto, Katsuhiko
    Nishio, Yoshihiko
    Ugi, Satoshi
    Sekine, Osamu
    Sugimoto, Toshiro
    Araki, Shin-ichi
    Isshiki, Keiji
    Sawaguchi, Makoto
    Shirahashi, Nobuo
    Haneda, Masakazu
    Kashiwagi, Atsunori
    DIABETES CARE, 2007, 30 (06) : 1581 - 1583
  • [35] Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial
    Guo Qiang
    Zhang Hengyao
    Li Mindian
    Zhao Ziyi
    Luo Yunlin
    Luo Yulei
    Cao Wenzhai
    Zhao Huan
    Zhu Ranran
    Lei Xingxing
    Chen Huizhen
    Gan Huakui
    Zuo Zhihuang
    Chen Qi
    Shi Cuimei
    Zhang Xinli
    Guo Jian
    Zhong Sen
    Chen Qiu
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2016, 36 (05) : 640 - 648
  • [36] A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Patients With Uncontrolled Type 2 Diabetes (vol 37, pg 625, 2014)
    Safren, Steven A.
    Gonzalez, Jeffrey S.
    Wexler, Deborah J.
    Psaros, Christina
    Delahanty, Linda M.
    Blashill, Aaron J.
    Margolina, Aleksandra I.
    Cagliero, Enrico
    DIABETES CARE, 2016, 39 (06) : 1065 - 1065
  • [37] Effects of Aerobic and Resistance Training on Hemoglobin A1c Levels in Patients With Type 2 Diabetes: A Randomized Controlled Trial (vol 304, pg 2253, 2010)
    Church, Timothy S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (09): : 892 - 892
  • [38] Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes
    Yiu, Yuen-Fung
    Yiu, Kai-Hang
    Siu, Chung-Wah
    Chan, Yap-Hang
    Li, Sheung-Wai
    Wong, Lai-Yung
    Lee, Stephen W. L.
    Tam, Sidney
    Wong, Eric W. K.
    Lau, Chu-Pak
    Cheung, Bernard M. Y.
    Tse, Hung-Fat
    ATHEROSCLEROSIS, 2013, 227 (01) : 140 - 146
  • [39] Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial
    Guo Qiang
    Zhang Hengyao
    Li Mindian
    Zhao Ziyi
    Luo Yunlin
    Luo Yulei
    Cao Wenzhai
    Zhao Huan
    Zhu Ranran
    Lei Xingxing
    Chen Huizhen
    Gan Huakui
    Zuo Zhihuang
    Chen Qi
    Shi Cuimei
    Zhang Xinli
    Guo Jian
    Zhong Sen
    Chen Qiu
    Journal of Traditional Chinese Medicine, 2016, 36 (05) : 640 - 648
  • [40] Randomized Controlled Trial of Ipragliflozin vs. Sitagliptin in Type 2 Diabetes Mellitus Patients
    Nakai, Kazuki
    Tsurutani, Yuuya
    Sugisawa, Chiho
    Saitou, Jun
    Omura, Masao
    Nishikawa, Tetsuo
    DIABETES, 2017, 66 : A335 - A335
12345